Back to Search
Start Over
British Society for Echocardiography and British Cardio-Oncology Society guideline for transthoracic echocardiographic assessment of adult cancer patients receiving anthracyclines and/or trastuzumab
- Source :
- Echo Research and Practice, Echo Research and Practice, Vol 8, Iss 1, Pp G1-G18 (2021)
- Publisher :
- Bio Scientifica
-
Abstract
- The subspecialty of cardio-oncology aims to reduce cardiovascular morbidity and mortality in patients with cancer or following cancer treatment. Cancer therapy can lead to a variety of cardiovascular complications, including left ventricular systolic dysfunction, pericardial disease, and valvular heart disease. Echocardiography is a key diagnostic imaging tool in the diagnosis and surveillance for many of these complications. The baseline assessment and subsequent surveillance of patients undergoing treatment with anthracyclines and/or human epidermal growth factor (EGF) receptor (HER) 2-positive targeted treatment (e.g. trastuzumab and pertuzumab) form a significant proportion of cardio-oncology patients undergoing echocardiography. This guideline from the British Society of Echocardiography and British Cardio-Oncology Society outlines a protocol for baseline and surveillance echocardiography of patients undergoing treatment with anthracyclines and/or trastuzumab. The methodology for acquisition of images and the advantages and disadvantages of techniques are discussed. Echocardiographic definitions for considering cancer therapeutics-related cardiac dysfunction are also presented.
Details
- Language :
- English
- ISSN :
- 20550464
- Database :
- OpenAIRE
- Journal :
- Echo Research and Practice, Echo Research and Practice, Vol 8, Iss 1, Pp G1-G18 (2021)
- Accession number :
- edsair.pmid.dedup....b3fa30ef095c1f6f88917c469401ed40